Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Understand when to choose long term vs short term investments. Make strategic decisions that align with your goals.
27,010 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Already own rental property but not seeing the cash flow you want? Learn proven strategies to your cash flow more by ...
A fresh U.S. government win could alter Palantir's growth trajectory and market perception. Here’s what investors sho...
J.B. Hunt edges ahead on margin strength in a soft freight market, while ZIM faces a sharp drop in rates and merger r...
In a market hungry for outsized gains, the idea of a spectacular growth stock before it erupts can be tempting. This ...
The Nasdaq trades near flat as investors weigh a Middle East deal and a SpaceX IPO. Markets face a cautious open as e...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....
NRG Energy announced a transformative deal that doubles its generation capacity to roughly 25 GW and targets 14% annu...
Oracle is sitting on a massive backlog that could redefine its AI trajectory in 2026. This deep dive breaks down what...
Three fast-casual names—Chipotle, Cava Group, and Sweetgreen—sit at the center of today’s restaurant stock debate. Th...
Markets react as Trump signals an interim Iran deal to reopen the Strait of Hormuz. The move could ease shipping disr...